ABT vs NUKKW · P/E 25, rev $44.33B vs $1.21B cap
Abbott Laboratories (ABT) versus Nukkleus Inc (NUKKW) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Nukkleus Inc (NUKKW) is a software - application company listed on US.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
NUKKW does not have a complete income-statement cache yet.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. NUKKW currently screens at market cap $1.21B.
Not investment advice. Open the ABT and NUKKW stock pages for the full models.
Not investment advice.